Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05048264 · ClinicalTrials.gov registry record

Effect of Corticosteroid Injections on Blood Glucose

A clinical trial, sponsored by Duke University.

Terminated
Registry status
38
Enrollment target

NCT05048264 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05048264 was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
38 participants
Enrollment target

Study Summary

The purpose of this study is to measure the effect of various corticosteroids administered to the shoulder, knee and hip joints in diabetic patients on resultant blood glucose readings.

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2023-05-04
Est. Completion 2024-09-16

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05048264

The ClinicalTrials.gov registry entry for NCT05048264 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05048264 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05048264 about?

NCT05048264 is a clinical study titled "Effect of Corticosteroid Injections on Blood Glucose". The purpose of this study is to measure the effect of various corticosteroids administered to the shoulder, knee and hip joints in diabetic patients on resultant blood glucose readings.

What is the current status of trial NCT05048264?

This trial is currently terminated. The enrollment target is 38 participants. The study started on 2023-05-04. Estimated completion is 2024-09-16.

Who is sponsoring clinical trial NCT05048264?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.